Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010
The exposure rate of screening for prostate cancer using prostate‐specific antigen (PSA) in Japan is still very low compared with that in the USA or western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8‐fold higher than in 2000. Therefore, there...
Gespeichert in:
| Veröffentlicht in: | International journal of urology 2010-10, Vol.17 (10), p.830-838 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 838 |
|---|---|
| container_issue | 10 |
| container_start_page | 830 |
| container_title | International journal of urology |
| container_volume | 17 |
| creator | Committee for Establishment of the Guidelines on Screening for Prostate Cancer Japanese Urological Association The Committee for Establishment of the Guidelines on Screening for Prostate Cancer |
| description | The exposure rate of screening for prostate cancer using prostate‐specific antigen (PSA) in Japan is still very low compared with that in the USA or western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8‐fold higher than in 2000. Therefore, there is an urgent need to determine the best available countermeasures to decrease the rate of prostate cancer death. PSA screening, which can reduce the risk of death as a result of prostate cancer, should be offered to all men at risk of developing prostate cancer with fact sheets showing updated benefits and drawbacks of screening for prostate cancer. |
| doi_str_mv | 10.1111/j.1442-2042.2010.02613.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_757459288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>757459288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5253-b2b0b6a51c381b6d7cc1d5b148bcfc0ea37ba58ddc4e6880ca5c6995486e8a63</originalsourceid><addsrcrecordid>eNqNkF9v0zAUxS00xMrgKyC_7SnFf-LEedjD1I2yMYGEWvFo2Tc3lbs0yexU68SXx6Gjz_jFvvb5XZ97CKGczXlan7dznuciEywXc8HSLRMFl_PDGzI7PZyRGat4lWleinPyPsYtY1wKrt-Rc8G0UIpVM_J7PdR2xJre28F2GJGuQ9_2Gw-2pdcx9uDt6PuOLve-xtYnCU3VEPo4Ji6LA4JvPFDbjX6DXeZsTN0iBMTOdxva9OGkpmA7wEB9RyfXH8jbxrYRP77uF2T15Xa1-Jo9_FjeLa4fMlBCycwJx1xhFQepuSvqEoDXyvFcO2iAoZWls0rXNeRYaM3AKiiqSuW6QG0LeUEuj22Tjac9xtHsfARs2zRvv4-mVGWuKqF1UuqjEpLhGLAxQ_A7G14MZ2YK3mzNlK-Z8jXTCOZv8OaQ0E-vn-zdDusT-C_pJLg6Cp59iy__3djc3a-nU-KzI-_jiIcTb8OjKUpZKvPr-9LcLKVYfPu5MqX8A3ybolc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>757459288</pqid></control><display><type>article</type><title>Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Committee for Establishment of the Guidelines on Screening for Prostate Cancer ; Japanese Urological Association ; The Committee for Establishment of the Guidelines on Screening for Prostate Cancer</creator><creatorcontrib>Committee for Establishment of the Guidelines on Screening for Prostate Cancer ; Japanese Urological Association ; The Committee for Establishment of the Guidelines on Screening for Prostate Cancer</creatorcontrib><description>The exposure rate of screening for prostate cancer using prostate‐specific antigen (PSA) in Japan is still very low compared with that in the USA or western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8‐fold higher than in 2000. Therefore, there is an urgent need to determine the best available countermeasures to decrease the rate of prostate cancer death. PSA screening, which can reduce the risk of death as a result of prostate cancer, should be offered to all men at risk of developing prostate cancer with fact sheets showing updated benefits and drawbacks of screening for prostate cancer.</description><identifier>ISSN: 0919-8172</identifier><identifier>EISSN: 1442-2042</identifier><identifier>DOI: 10.1111/j.1442-2042.2010.02613.x</identifier><identifier>PMID: 20825509</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Early Detection of Cancer - standards ; guidelines ; Humans ; Japan ; Male ; prostate cancer ; Prostate-Specific Antigen - blood ; Prostate-Specific Antigen - standards ; Prostatic Neoplasms - diagnosis ; PSA ; Risk Assessment ; screening</subject><ispartof>International journal of urology, 2010-10, Vol.17 (10), p.830-838</ispartof><rights>2010 The Japanese Urological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5253-b2b0b6a51c381b6d7cc1d5b148bcfc0ea37ba58ddc4e6880ca5c6995486e8a63</citedby><cites>FETCH-LOGICAL-c5253-b2b0b6a51c381b6d7cc1d5b148bcfc0ea37ba58ddc4e6880ca5c6995486e8a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1442-2042.2010.02613.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1442-2042.2010.02613.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20825509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Committee for Establishment of the Guidelines on Screening for Prostate Cancer</creatorcontrib><creatorcontrib>Japanese Urological Association</creatorcontrib><creatorcontrib>The Committee for Establishment of the Guidelines on Screening for Prostate Cancer</creatorcontrib><title>Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010</title><title>International journal of urology</title><addtitle>Int J Urol</addtitle><description>The exposure rate of screening for prostate cancer using prostate‐specific antigen (PSA) in Japan is still very low compared with that in the USA or western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8‐fold higher than in 2000. Therefore, there is an urgent need to determine the best available countermeasures to decrease the rate of prostate cancer death. PSA screening, which can reduce the risk of death as a result of prostate cancer, should be offered to all men at risk of developing prostate cancer with fact sheets showing updated benefits and drawbacks of screening for prostate cancer.</description><subject>Early Detection of Cancer - standards</subject><subject>guidelines</subject><subject>Humans</subject><subject>Japan</subject><subject>Male</subject><subject>prostate cancer</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostate-Specific Antigen - standards</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>PSA</subject><subject>Risk Assessment</subject><subject>screening</subject><issn>0919-8172</issn><issn>1442-2042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF9v0zAUxS00xMrgKyC_7SnFf-LEedjD1I2yMYGEWvFo2Tc3lbs0yexU68SXx6Gjz_jFvvb5XZ97CKGczXlan7dznuciEywXc8HSLRMFl_PDGzI7PZyRGat4lWleinPyPsYtY1wKrt-Rc8G0UIpVM_J7PdR2xJre28F2GJGuQ9_2Gw-2pdcx9uDt6PuOLve-xtYnCU3VEPo4Ji6LA4JvPFDbjX6DXeZsTN0iBMTOdxva9OGkpmA7wEB9RyfXH8jbxrYRP77uF2T15Xa1-Jo9_FjeLa4fMlBCycwJx1xhFQepuSvqEoDXyvFcO2iAoZWls0rXNeRYaM3AKiiqSuW6QG0LeUEuj22Tjac9xtHsfARs2zRvv4-mVGWuKqF1UuqjEpLhGLAxQ_A7G14MZ2YK3mzNlK-Z8jXTCOZv8OaQ0E-vn-zdDusT-C_pJLg6Cp59iy__3djc3a-nU-KzI-_jiIcTb8OjKUpZKvPr-9LcLKVYfPu5MqX8A3ybolc</recordid><startdate>201010</startdate><enddate>201010</enddate><creator>Committee for Establishment of the Guidelines on Screening for Prostate Cancer</creator><creator>Japanese Urological Association</creator><creator>The Committee for Establishment of the Guidelines on Screening for Prostate Cancer</creator><general>Blackwell Publishing Asia</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201010</creationdate><title>Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5253-b2b0b6a51c381b6d7cc1d5b148bcfc0ea37ba58ddc4e6880ca5c6995486e8a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Early Detection of Cancer - standards</topic><topic>guidelines</topic><topic>Humans</topic><topic>Japan</topic><topic>Male</topic><topic>prostate cancer</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostate-Specific Antigen - standards</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>PSA</topic><topic>Risk Assessment</topic><topic>screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Committee for Establishment of the Guidelines on Screening for Prostate Cancer</creatorcontrib><creatorcontrib>Japanese Urological Association</creatorcontrib><creatorcontrib>The Committee for Establishment of the Guidelines on Screening for Prostate Cancer</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><aucorp>Committee for Establishment of the Guidelines on Screening for Prostate Cancer</aucorp><aucorp>Japanese Urological Association</aucorp><aucorp>The Committee for Establishment of the Guidelines on Screening for Prostate Cancer</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010</atitle><jtitle>International journal of urology</jtitle><addtitle>Int J Urol</addtitle><date>2010-10</date><risdate>2010</risdate><volume>17</volume><issue>10</issue><spage>830</spage><epage>838</epage><pages>830-838</pages><issn>0919-8172</issn><eissn>1442-2042</eissn><abstract>The exposure rate of screening for prostate cancer using prostate‐specific antigen (PSA) in Japan is still very low compared with that in the USA or western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8‐fold higher than in 2000. Therefore, there is an urgent need to determine the best available countermeasures to decrease the rate of prostate cancer death. PSA screening, which can reduce the risk of death as a result of prostate cancer, should be offered to all men at risk of developing prostate cancer with fact sheets showing updated benefits and drawbacks of screening for prostate cancer.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>20825509</pmid><doi>10.1111/j.1442-2042.2010.02613.x</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0919-8172 |
| ispartof | International journal of urology, 2010-10, Vol.17 (10), p.830-838 |
| issn | 0919-8172 1442-2042 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_757459288 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Early Detection of Cancer - standards guidelines Humans Japan Male prostate cancer Prostate-Specific Antigen - blood Prostate-Specific Antigen - standards Prostatic Neoplasms - diagnosis PSA Risk Assessment screening |
| title | Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T14%3A21%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Updated%20Japanese%20Urological%20Association%20Guidelines%20on%20prostate-specific%20antigen-based%20screening%20for%20prostate%20cancer%20in%202010&rft.jtitle=International%20journal%20of%20urology&rft.aucorp=Committee%20for%20Establishment%20of%20the%20Guidelines%20on%20Screening%20for%20Prostate%20Cancer&rft.date=2010-10&rft.volume=17&rft.issue=10&rft.spage=830&rft.epage=838&rft.pages=830-838&rft.issn=0919-8172&rft.eissn=1442-2042&rft_id=info:doi/10.1111/j.1442-2042.2010.02613.x&rft_dat=%3Cproquest_cross%3E757459288%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=757459288&rft_id=info:pmid/20825509&rfr_iscdi=true |